-
$0
0.0% of portfolio
-
Q1 2025
Added 205.13%
$43.4B
$74,000
0.0% of portfolio
717
Q1 2025
Reduced 17.59%
-
$0
0.0% of portfolio
-
Q1 2025
New
$236B
$74,000
0.0% of portfolio
421
Q1 2025
Added 12.87%
$7.6B
$73,000
0.0% of portfolio
2,234
Q1 2025
Added 3,961.82%
$17.8B
$73,000
0.0% of portfolio
1,125
Q1 2025
Added 0.9%
$37B
$73,000
0.0% of portfolio
3,785
Q1 2025
Added 46.08%
$23.3B
$73,000
0.0% of portfolio
1,026
Q1 2025
Added 44.71%
$2.24B
$73,000
0.0% of portfolio
2,500
Q4 2023
Reduced 37.5%
$70.1B
$72,000
0.0% of portfolio
474
Q1 2025
Reduced 1.46%
$0
$71,000
0.0% of portfolio
638
Q2 2023
Reduced 43.29%
$15.3B
$71,000
0.0% of portfolio
768
Q3 2023
Reduced 32.81%
$0
$71,000
0.0% of portfolio
966
Q1 2025
Added 0.31%
$2.69B
$70,000
0.0% of portfolio
1,102
Q4 2024
Added 0.18%
$7.96B
$70,000
0.0% of portfolio
950
Q1 2025
Reduced 9.52%
$0
$70,000
0.0% of portfolio
2,280
Q1 2023
New
Palvella Therapeutics Inc Ne
-
$0
0.0% of portfolio
-
Q1 2025
New
$0
$70,000
0.0% of portfolio
8,608
Q1 2025
Added 1.77%
Oaktree Specialty Lending CO
-
$0
0.0% of portfolio
-
Q1 2025
Added 2.36%
$922M
$69,000
0.0% of portfolio
3,740
Q2 2024
Reduced 5.32%
$31.6B
$69,000
0.0% of portfolio
717
Q1 2025
Reduced 21.04%
$15.4B
$69,000
0.0% of portfolio
1,010
Q1 2025
Reduced 5.87%
$0
$69,000
0.0% of portfolio
1,460
Q1 2025
Reduced 55.39%
$0
$69,000
0.0% of portfolio
1,611
Q1 2025
Added 68.87%
$30.3B
$72,000
0.0% of portfolio
1,275
Q1 2025
Reduced 90.11%
$0
$69,000
0.0% of portfolio
1,361
Q1 2025
Added 0.07%
-
$0
0.0% of portfolio
-
Q1 2025
New
$70.4B
$68,000
0.0% of portfolio
859
Q1 2025
Added 62.69%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 2.4%
$7.99B
$67,000
0.0% of portfolio
543
Q2 2024
Reduced 1.09%
$0
$67,000
0.0% of portfolio
1,281
Q1 2025
Added 0.08%
$9.8B
$67,000
0.0% of portfolio
980
Q1 2025
Reduced 9.76%
$2.48B
$66,000
0.0% of portfolio
3,178
Q1 2025
Reduced 56.32%
$0
$66,000
0.0% of portfolio
1,294
Q1 2025
Added 4.44%
$15.2B
$66,000
0.0% of portfolio
1,034
Q1 2025
Reduced 0.48%
$16.8B
$66,000
0.0% of portfolio
650
Q1 2025
Added 2,066.67%
$21.5B
$66,000
0.0% of portfolio
2,294
Q1 2025
Added 428.57%
$12.2B
$65,000
0.0% of portfolio
333
Q1 2025
Added 11.74%
$51.9B
$64,000
0.0% of portfolio
989
Q1 2025
Reduced 1.3%
$3.28B
$64,000
0.0% of portfolio
24
Q1 2025
Added 14.29%
$15.2B
$64,000
0.0% of portfolio
879
Q1 2025
Reduced 16.44%
$0
$64,000
0.0% of portfolio
558
Q4 2021
Added 2.39%
$5.14B
$64,000
0.0% of portfolio
704
Q4 2024
Reduced 1.26%
$0
$64,000
0.0% of portfolio
1,109
Q1 2025
New
$39.4B
$64,000
0.0% of portfolio
277
Q1 2025
Added 37.13%
$428M
$63,000
0.0% of portfolio
4,837
Q3 2022
Reduced 75.61%
$1.25B
$63,000
0.0% of portfolio
2,325
Q1 2025
Reduced 0.51%
$0
$63,000
0.0% of portfolio
2,993
Q3 2024
Added 50.18%
-
$0
0.0% of portfolio
-
Q1 2025
New
$0
$63,000
0.0% of portfolio
5,289
Q1 2025
Added 2.48%